Platelet-derived growth factor-mediated gliomagenesis and brain tumor recruitment

被引:36
作者
Fomchenko, Elena I.
Holland, Eric C.
机构
[1] Mem Sloan Kettering Canc Ctr, Dept Surg Neurosurg, New York, NY 10021 USA
[2] Mem Sloan Kettering Canc Ctr, Dept Canc Biol & Genet, New York, NY 10021 USA
[3] Mem Sloan Kettering Canc Ctr, Dept Canc Biol, New York, NY 10021 USA
[4] Mem Sloan Kettering Canc Ctr, Dept Neurol, New York, NY 10021 USA
关键词
D O I
10.1016/j.nec.2006.10.006
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Platelet-derived growth factor (PDGF) is a growth factor family of ligands and receptors known to activate phosphatidylinositol 3-kinase, mitogen-activated protein kinase, Jak family kinase, Src family kinase, and phospholipase C gamma signal transduction pathways, some of which have been causally linked to glioma formation. Extensive involvement of PDGF in development and its implication in a variety of pathologic conditions, including gliomagenesis, are mediated not only by autocrine effects but by paracrine effects. Many researchers view brain tumors as clonal entities derived from the cancer stem cell; however, recent documentation of the importance of the tumor microenvironment for glioma initiation and progression as well as the ability of neural stem or progenitor cells to migrate toward the sites of injury or tumor formation reveals additional complexities in brain tumorigenesis. Paracrine effects of PDGF in animal models of gliomagenesis, continued adult neurogenesis capable of increasing in response to brain injury, and the growth factor-rich environment of brain tumors suggest that recruitment may play a role in gliomagenesis. In this view, glioma formation involves recruitment of cells from the adjacent brain and possibly other sites.
引用
收藏
页码:39 / +
页数:21
相关论文
共 179 条
[1]   Expression analysis of PDGF-C in adult and developing mouse tissues [J].
Aase, K ;
Abramsson, A ;
Karlsson, L ;
Betsholtz, C ;
Eriksson, U .
MECHANISMS OF DEVELOPMENT, 2002, 110 (1-2) :187-191
[2]   Astrocyte-endothelial interactions at the blood-brain barrier [J].
Abbott, NJ ;
Rönnbäck, L ;
Hansson, E .
NATURE REVIEWS NEUROSCIENCE, 2006, 7 (01) :41-53
[3]  
Aboody KS, 2001, P NATL ACAD SCI USA, V98, P777
[4]   1-HydroxyPGE1 reduces infarction volume in mouse transient cerebral ischemia [J].
Ahmad, M ;
Saleem, S ;
Zhuang, H ;
Ahmad, AS ;
Echeverria, V ;
Sapirstein, A ;
Doré, S .
EUROPEAN JOURNAL OF NEUROSCIENCE, 2006, 23 (01) :35-42
[5]   Identification of neural stem cells in the adult vertebrate brain [J].
Alvarez-Buylla, A ;
Seri, B ;
Doetsch, F .
BRAIN RESEARCH BULLETIN, 2002, 57 (06) :751-758
[6]   Fusion of bone-marrow-derived cells with Purkinje neurons, cardiomyocytes and hepatocytes [J].
Alvarez-Dolado, M ;
Pardal, R ;
Garcia-Vardugo, JM ;
Fike, JR ;
Lee, HO ;
Pfeffer, K ;
Lois, C ;
Morrison, SJ ;
Alvarez-Buylla, A .
NATURE, 2003, 425 (6961) :968-973
[7]   Selective destruction of glioblastoma cells by interference with the activity or expression of ATF5 [J].
Angelastro, JM ;
Canoll, PD ;
Kuo, J ;
Weicker, M ;
Costa, A ;
Bruce, JN ;
Greene, LA .
ONCOGENE, 2006, 25 (06) :907-916
[8]   Arundic Acid (ONO-2506) Ameliorates Delayed Ischemic Brain Damage by Preventing Astrocytic Overproduction of S100B [J].
Asano, T. ;
Mori, T. ;
Shimoda, T. ;
Shinagawa, R. ;
Satoh, S. ;
Yada, N. ;
Katsumata, S. ;
Matsuda, S. ;
Kagamiishi, Y. ;
Tateishi, N. .
CNS & NEUROLOGICAL DISORDERS-DRUG TARGETS, 2005, 4 (02) :127-142
[9]   Development of gliomas: potential role of asymmetrical cell division of neural stem cells [J].
Berger, F ;
Gay, E ;
Pelletier, L ;
Tropel, P ;
Wion, D .
LANCET ONCOLOGY, 2004, 5 (08) :511-514
[10]   PDGF-D is a specific, protease-activated ligand for the PDGF β-receptor [J].
Bergsten, E ;
Uutela, M ;
Li, XR ;
Pietras, K ;
Östman, A ;
Heldin, CH ;
Alitalo, K ;
Eriksson, U .
NATURE CELL BIOLOGY, 2001, 3 (05) :512-516